Since a large number of cancers, and especially blood cancers, exhibit loss of cellular identity [37], knocking the SMC1A-R586W mutation into mESCs allows for investigation of potential aberrant cellular identity and the molecular mechanisms that underlie it. The gene discussed is SMC1A; the disease is cancer.